Interestingly, Kaplan–Meier survival curves showed a non-statistically significant trend towards low PSA concentrations being associated with worse prognosis in low-risk patients with T4 stage prostate cancer, similar to the high-risk group. This evidence concerns the gene KLK3 and prostate cancer.